The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
International patterns and trends in ovarian cancer incidence, overall and by histologic subtype: Ovarian cancer trends
Open accessAbstract
Internationally, ovarian cancer is the 7th leading cancer diagnosis and 8th leading cause of cancer mortality among women. Ovarian cancer incidence varies by region, particularly when comparing high vs. low-income countries. Temporal changes in reproductive factors coupled with shifts in diagnostic criteria may have influenced incidence trends of ovarian cancer and relative rates by histologic subtype. Accordingly, we evaluated trends in ovarian cancer incidence overall (1973-1977 to 2003-2007) and by histologic subtype (1988-1992 to 2003-2007) using volumes IV-IX of the Cancer Incidence in Five Continents database (CI5plus) and CI5X (volume X) database. Annual percent changes were calculated for ovarian cancer incidence trends, and rates of histologic subtypes for individual countries were compared to overall international incidence. Ovarian cancer incidence rates were stable across regions, although there were notable increases in Eastern/Southern Europe (e.g., Poland: Annual Percent Change (APC) 1.6%, p = 0.02) and Asia (e.g., Japan: APC 1.7%, p = 0.01) and decreases in Northern Europe (e.g., Denmark: APC -0.7%, p = 0.01) and North America (e.g., US Whites: APC -0.9%, p < 0.01). Relative proportions of histologic subtypes were similar across countries, except for Asian nations, where clear cell and endometrioid carcinomas comprised a higher proportion of the rate and serous carcinomas comprised a lower proportion of the rate than the worldwide distribution. Geographic variation in temporal trends of ovarian cancer incidence and differences in the distribution of histologic subtype may be partially explained by reproductive and genetic factors. Thus, histology-specific ovarian cancer should continue to be monitored to further understand the etiology of this neoplasm.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Self-citationGlobal cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Self-citationEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Self-citationCancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Cancer Incidence in Five Continents
(1966) · doi:10.1007/978-3-642-85849-9 · Cited by 5,936
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
Kurman, R. J., & Shih, I.-M. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.03.003 · Cited by 1,073
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Kwan, E., Jack, E., Vesprini, D. J., Kuperstein, G., Abrahamson, J. L. A., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318787 · Cited by 986
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Ovarian cancer: Epidemiology, biology, and prognostic factors
Holschneider, C. H., & Berek, J. S. (2000) · Seminars in Surgical Oncology · doi:10.1002/1098-2388(200007/08)19:1<3::aid-ssu2>3.0.co;2-s · Cited by 694
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
Pal, T., Permuth‐Wey, J., Betts, J. A., Krischer, J. P., Fiorica, J., Arango, H., LaPolla, J., Hoffman, M., Martino, M. A., Wakeley, K., et al. (2005) · Cancer · doi:10.1002/cncr.21536 · Cited by 691
Struewing, J. P., Abeliovich, D., Peretz, T., Avishai, N., Kaback, M. M., Collins, F. S., & Brody, L. C. (1995) · Nature Genetics · doi:10.1038/ng1095-198 · Cited by 647
Bray, F., Ferlay, J., Laversanne, M., Brewster, D. H., Gombe Mbalawa, C., Kohler, B., Piñeros, M., Steliarova‐Foucher, E., Swaminathan, R., Antoni, S., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29670 · Cited by 643
Self-citationMissmer, S. A. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh275 · Cited by 616
The Epidemiology of Endometriosis
CRAMER, D. W., & MISSMER, S. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02761.x · Cited by 539
Wentzensen, N., Poole, E. M., Trabert, B., White, E., Arslan, A. A., Patel, A. V., Setiawan, V. W., Visvanathan, K., Weiderpass, E., Adami, H.-O., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.66.8178 · Cited by 514
Self-citationModan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450401 · Cited by 385
Oddoux, C., Struewing, J. P., Clayton, C. M., Neuhausen, S., Brody, L. C., Kaback, M., Haas, B., Norton, L., Borgen, P., Jhanwar, S., et al. (1996) · Nature Genetics · doi:10.1038/ng1096-188 · Cited by 381
Ovarian cancer: epidemiology and risk factors
La Vecchia, C. (2017) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000217 · Cited by 327
Cancer incidence in five continents : a technical report
Doll, R., Payne, P. M., & Waterhouse, J. A. H. (1966) · Springer eBooks · Cited by 319
Epidemiology of endometriosis among parous women
SANGIHAGHPEYKAR, H., & POINDEXTERIII, A. (1995) · Obstetrics & Gynecology · doi:10.1016/0029-7844(95)00074-2 · Cited by 288
Sant, M., Chirlaque Lopez, M. D., Agresti, R., Sánchez Pérez, M. J., Holleczek, B., Bielska-Lasota, M., Dimitrova, N., Innos, K., Katalinic, A., Langseth, H., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.07.022 · Cited by 274
Determinants of Ovarian Cancer Risk. I. Reproductive Experiences and Family History 23
(1983) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/71.4.711 · Cited by 256
Ovarian carcinoma pathology and genetics: recent advances
Gilks, C. B., & Prat, J. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.04.017 · Cited by 249
Histological classification of ovarian cancer
Kaku, T., Ogawa, S., Kawano, Y., Ohishi, Y., Kobayashi, H., Hirakawa, T., & Nakano, H. (2003) · Medical Electron Microscopy · doi:10.1007/s007950300002 · Cited by 233
An international assessment of ovarian cancer incidence and mortality
Lowe, K. A., Chia, V. M., Taylor, A., O’Malley, C., Kelsh, M., Mohamed, M., Mowat, F. S., & Goff, B. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.03.026 · Cited by 220
Global epidemiology of hysterectomy: possible impact on gynecological cancer rates
Hammer, A., Rositch, A. F., Kahlert, J., Gravitt, P. E., Blaakaer, J., & Søgaard, M. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.02.019 · Cited by 187
Endometriosis-Associated Ovarian Cancer: A Review of Pathogenesis
Worley, M., Welch, W., Berkowitz, R., & Ng, S.-W. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14035367 · Cited by 175
Graphical Presentation of Trends in Rates
Devesa, S. S., Donaldson, J., & Fears, T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/141.4.300 · Cited by 159
Global trends and predictions in ovarian cancer mortality
Malvezzi, M., Carioli, G., Rodríguez, T., Negri, E., & Vecchia, C. L. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw306 · Cited by 149
Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2
Liede, A., & Narod, S. (2002) · Human Mutation · doi:10.1002/humu.10154 · Cited by 148
Europe the continent with the lowest fertility
The ESHRE Capri Workshop Group (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq023 · Cited by 121
Sung, P., Chang, Y., Chao, K.-C., & Chuang, C.-M. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.02.016 · Cited by 112
Zbuk, K. M., & Anand, S. S. (2011) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2008.083774 · Cited by 103
Klint, Å., Tryggvadóttír, L., Bray, F., Gislum, M., Hakulinen, T. R., Storm, H. H., & Engholm, G. (2010) · Acta Oncologica · doi:10.3109/02841861003691945 · Cited by 93
Self-citationYang, H., Anderson, W. F., Rosenberg, P. S., Trabert, B. L., Gierach, G. L., Wentzensen, N., Cronin, K. A., & Sherman, M. E. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.5758 · Cited by 85
Self-citationReproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study
Braem, M. G. M., Onland‐Moret, N. C., van den Brandt, P. A., Goldbohm, R. A., Peeters, P. H. M., Kruitwagen, R. F. P. M., & Schouten, L. J. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq264 · Cited by 69
Silva, I. D. S., & Swerdlow, A. J. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.360 · Cited by 67
Segi, M., Fujisaku, S., & Kurihara, M. (1957) · PubMed · Cited by 64
Genetics and genomic medicine in I srael
Zlotogora, J. (2014) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.73 · Cited by 63
Arumugam, K., & Templeton, A. A. (1992) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1992.tb01932.x · Cited by 58
Merrill, R. M. (2006) · Annals of Epidemiology · doi:10.1016/j.annepidem.2006.06.001 · Cited by 39
Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways
Galic, V., Coleman, R. L., & Herzog, T. J. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113139990002 · Cited by 20
Li, J., Chen, Y., Mo, Z., & Li, L. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.03.026 · Cited by 11
Yan, Y., Wu, R., Li, S., & He, J. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.03.015 · Cited by 7
Cited by
Ovarian cancer statistics, 2018
Torre, L. A., Trabert, B., DeSantis, C. E., Miller, K. D., Samimi, G., Runowicz, C. D., Gaudet, M. M., Jemal, A., & Siegel, R. L. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21456 · Cited by 3,492
Self-citationOvarian cancer in the world: epidemiology and risk factors
Momenimovahed, Z., Tiznobaik, A., Taheri, S., & Salehiniya, H. (2019) · International Journal of Women's Health · doi:10.2147/ijwh.s197604 · Cited by 912
Ediriweera, M. K., Tennekoon, K. H., & Samarakoon, S. R. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.05.012 · Cited by 740
Czystowska-Kuzmicz, M., Sosnowska, A., Nowis, D., Ramji, K., Szajnik, M., Chlebowska-Tuz, J., Wolinska, E., Gaj, P., Grazul, M., Pilch, Z., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10979-3 · Cited by 312
Endometriosis and cancer: a systematic review and meta-analysis
Kvaskoff, M., Mahamat-Saleh, Y., Farland, L. V., Shigesi, N., Terry, K. L., Harris, H. R., Roman, H., Becker, C. M., As-Sanie, S., Zondervan, K. T., et al. (2021) · Human Reproduction Update · doi:10.1093/humupd/dmaa045 · Cited by 303
Metadata
- Authors
- Coburn, S. B., Bray, F., Sherman, M. E., & Trabert, B.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2017-03-21
- Volume
- 140
- Issue
- 11
- Pages
- 2451-2460
- ISSN
- 0020-7136 (ISSN-L)
- OpenAlex
- W2593625946
- Cited by
- 453
- References
- 44
- FWCI
- 28.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.